Double maintains 7 strategies that include NBIX - Neurocrine Biosciences, Inc.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BNO | 0.02% | $99.25M | 1% |
TOTL | 0.02% | $3.51B | 0.55% |
MLN | 0.03% | $534.56M | 0.24% |
BSMR | -0.04% | $235.44M | 0.18% |
OILK | 0.05% | $67.85M | 0.69% |
GSG | 0.12% | $1.05B | 0.75% |
EWW | -0.20% | $1.50B | 0.5% |
BSSX | 0.21% | $76.01M | 0.18% |
SCHO | -0.22% | $10.65B | 0.03% |
IBMS | -0.24% | $46.94M | 0.18% |
DBO | 0.24% | $202.41M | 0.77% |
YEAR | 0.25% | $1.28B | 0.25% |
CANE | -0.31% | $11.28M | 0.29% |
GSY | -0.32% | $2.73B | 0.23% |
SGOV | 0.33% | $39.98B | 0.09% |
ULST | -0.33% | $585.14M | 0.2% |
TFLO | 0.34% | $6.75B | 0.15% |
EQLS | 0.35% | $4.80M | 1% |
BSMW | -0.42% | $101.29M | 0.18% |
SCHR | 0.45% | $10.47B | 0.03% |
SeekingAlpha
Impax Small Cap Fundâs equities posted their second consecutive positive quarter during a period that was dominated by the US presidential elections and its ramifications.
Yahoo
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the presentation of new data from a real-world study showing that all patients with tardive dyskinesia achieved a therapeutic dose with INGREZZA® (valbenazine) capsules upon initiation of treatment. This retrospective cohort study will be presented at the Academy of Managed Care Pharmacy 2025 Annual Meeting in Houston, Texas.
SeekingAlpha
Baird Small/Mid Cap Growth portfolio increased +5.1% in the fourth quarter, net of fees, compared to the +2.4% increase in our primary benchmark, the Russell 2500 Growth Index.
SeekingAlpha
Franklin Biotechnology Discovery Fund Q4 2024 Commentary
Yahoo
Over the last 7 days, the United States market has risen by 1.8%, contributing to a 10% increase over the past year, with earnings projected to grow by 14% annually in the coming years. In this favorable environment, identifying high growth tech stocks involves focusing on companies that demonstrate strong innovation and scalability potential within this dynamic sector.
Yahoo
Of the 103 patients who completed the Phase III trial, more than half witnessed remission from a drug-induced condition that manifests as involuntary tics.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ASTH | -0.01% | $1.50B | -28.69% | 0.00% |
TENB | -0.03% | $4.23B | -26.49% | 0.00% |
MLCO | 0.05% | $2.24B | -29.50% | 0.00% |
AOS | 0.06% | $9.49B | -25.41% | 2.08% |
CRTO | -0.07% | $1.93B | +0.42% | 0.00% |
CMS | 0.08% | $22.33B | +25.86% | 2.76% |
VLO | -0.08% | $42.02B | -25.92% | 3.65% |
CF | -0.10% | $13.29B | -4.06% | 2.51% |
CLX | 0.12% | $18.19B | +0.54% | 3.24% |
OPCH | -0.12% | $5.71B | +8.14% | 0.00% |
SYPR | -0.13% | $37.52M | -3.55% | 0.00% |
LRN | 0.14% | $5.71B | +112.31% | 0.00% |
PRA | -0.17% | $1.20B | +85.99% | 0.00% |
BTCT | 0.18% | $20.15M | +14.57% | 0.00% |
NSA | 0.18% | $2.98B | +4.58% | 5.91% |
EG | 0.18% | $15.69B | -5.75% | 2.22% |
CHE | -0.18% | $9.00B | -3.02% | 0.31% |
KNOP | 0.19% | $260.66M | +43.40% | 1.46% |
ASC | 0.20% | $390.80M | -42.98% | 10.22% |
BPT | -0.20% | $12.33M | -81.88% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SWI | -27.57% | $3.19B | +62.24% | 0.00% |
OOMA | -22.47% | $359.10M | +59.09% | 0.00% |
ESE | -19.17% | $4.14B | +53.44% | 0.22% |
BOX | -18.32% | $4.53B | +13.12% | 0.00% |
TTWO | -16.46% | $37.26B | +39.13% | 0.00% |
POST | -16.17% | $6.54B | +11.31% | 0.00% |
DOCS | -14.57% | $10.87B | +125.49% | 0.00% |
TRVG | -14.56% | $104.93M | +63.70% | 0.00% |
PPC | -14.13% | $11.62B | +59.32% | 0.00% |
LITB | -12.17% | $41.93M | -46.48% | 0.00% |
EXPE | -11.08% | $21.63B | +28.56% | 0.26% |
TEF | -10.70% | $26.35B | +6.62% | 6.43% |
MVO | -10.14% | $64.63M | -49.96% | 23.78% |
EZPW | -9.57% | $841.66M | +40.29% | 0.00% |
SEG | -9.53% | $269.93M | -17.45% | 0.00% |
G | -9.19% | $8.88B | +57.41% | 1.30% |
CIG.C | -8.53% | $2.35B | +14.03% | 0.00% |
NOMD | -8.35% | $3.02B | +4.08% | 3.10% |
TSN | -8.26% | $21.91B | +8.55% | 3.09% |
CCEC | -8.19% | $1.17B | +17.80% | 2.99% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BILL | 44.15% | $4.76B | -25.55% | 0.00% |
GHM | 35.77% | $327.09M | -9.53% | 0.00% |
PLRX | 35.52% | $86.34M | -90.23% | 0.00% |
ATR | 33.41% | $9.93B | +6.85% | 1.19% |
CTS | 30.86% | $1.26B | -6.74% | 0.43% |
AVTR | 30.68% | $11.09B | -35.59% | 0.00% |
TECH | 30.47% | $9.23B | -13.98% | 0.58% |
IDYA | 29.66% | $1.43B | -61.21% | 0.00% |
NCNO | 29.00% | $2.62B | -35.64% | 0.00% |
ARW | 28.91% | $5.45B | -18.61% | 0.00% |
IONS | 28.78% | $4.56B | -34.42% | 0.00% |
CRL | 28.63% | $7.63B | -42.43% | 0.00% |
GPRO | 28.37% | $98.12M | -71.28% | 0.00% |
AMZN | 28.00% | $2.08T | +7.46% | 0.00% |
SCVL | 27.73% | $625.01M | -34.94% | 2.77% |
SKX | 27.45% | $8.82B | +0.85% | 0.00% |
NWL | 27.24% | $2.61B | -16.84% | 4.94% |
ALNY | 27.13% | $34.71B | +76.91% | 0.00% |
QGEN | 27.10% | $8.71B | -7.16% | 0.00% |
LAD | 27.06% | $8.04B | +7.46% | 0.76% |
Current Value
$105.321 Year Return
Current Value
$105.321 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -22.04% | $416.76M | 1.43% |
VIXY | -19.57% | $195.31M | 0.85% |
TAIL | -18.18% | $87.65M | 0.59% |
IVOL | -8.18% | $476.36M | 1.02% |
FLDR | -7.48% | $775.30M | 0.15% |
TPMN | -7.41% | $33.32M | 0.65% |
FXY | -5.99% | $549.84M | 0.4% |
XHLF | -5.98% | $1.06B | 0.03% |
DBA | -5.94% | $829.48M | 0.93% |
GBIL | -5.52% | $6.30B | 0.12% |
JMST | -4.92% | $3.54B | 0.18% |
TBLL | -4.68% | $2.13B | 0.08% |
FLMI | -4.56% | $613.41M | 0.3% |
UUP | -4.53% | $325.79M | 0.77% |
USCI | -4.05% | $240.82M | 1.07% |
BOXX | -3.99% | $5.77B | 0.1949% |
USDU | -3.81% | $206.96M | 0.5% |
WEAT | -3.34% | $115.75M | 0.28% |
UGA | -3.33% | $87.23M | 0.97% |
KMLM | -3.19% | $218.49M | 0.9% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
PBE | 43.59% | $224.98M | 0.58% |
FBT | 41.54% | $1.08B | 0.56% |
BBH | 41.19% | $358.88M | 0.35% |
XBI | 40.77% | $4.76B | 0.35% |
IBB | 40.13% | $5.61B | 0.45% |
PINK | 36.57% | $138.92M | 0.5% |
FXH | 32.80% | $954.59M | 0.62% |
XPH | 32.13% | $158.14M | 0.35% |
GNOM | 32.06% | $47.13M | 0.5% |
VHT | 30.32% | $16.17B | 0.09% |
TCAF | 29.51% | $3.90B | 0.31% |
CGUS | 29.09% | $4.89B | 0.33% |
IYH | 28.98% | $3.15B | 0.39% |
FHLC | 28.93% | $2.65B | 0.084% |
HLAL | 28.68% | $558.07M | 0.5% |
SECT | 28.51% | $1.83B | 0.78% |
VBK | 28.13% | $17.32B | 0.07% |
NTSX | 28.05% | $1.13B | 0.2% |
USMC | 28.05% | $2.50B | 0.12% |
ESGV | 28.01% | $9.58B | 0.09% |